Lucid Diagnostics Inc.
LUCD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $114 | $103 | $47 |
| - Cash | $47 | $31 | $25 | $22 |
| + Debt | $1 | $28 | $35 | $21 |
| Enterprise Value | – | $110 | $113 | $46 |
| Revenue | $1,211 | $1 | $1 | $1 |
| % Growth | 104,027.3% | 40.5% | -30.8% | – |
| Gross Profit | -$486 | -$1 | -$1 | -$1 |
| % Margin | -40.1% | -53.5% | -87.3% | -79.2% |
| EBITDA | -$9,954 | -$4 | -$27 | -$11 |
| % Margin | -822% | -362.1% | -3,222% | -945% |
| Net Income | -$10,397 | -$4 | -$27 | -$12 |
| % Margin | -858.5% | -381.7% | -3,249.8% | -964.2% |
| EPS Diluted | -0.1 | -0.08 | -0.52 | -0.2 |
| % Growth | -25.5% | 84.7% | -160% | – |
| Operating Cash Flow | -$11 | -$11 | -$12 | -$10 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$11 | -$11 | -$13 | -$10 |